A Hacker News post alleges that OpenEvidence is bribing spouses of CMI and Genentech leadership to block competitors. The claim appears in a submission titled "OpenEvidence is bribing spouses of CMI and Genentech leadership to block competitors" which garnered 3 points and zero comments at the time of capture. No supporting evidence, documentation, or named sources are provided in the original post.

The accusation implies a coordinated effort to influence decision-makers through personal connections rather than merit-based competition. OpenEvidence, a medical AI company, would face serious legal and ethical violations if proven true, including potential FCPA and anti-kickback statute breaches. CMI and Genentech represent major players in healthcare and biotechnology, making any improper influence particularly consequential. As of publication, no regulatory filings, lawsuits, or corporate responses have surfaced to substantiate or refute the claim. The absence of discussion threads suggests limited community engagement or immediate skepticism.

Readers should treat this as an unverified allegation pending investigation or official statement.